Effect of intraperitoneal docetaxel on ovarian function in mice

References

• Abusief, M.E., et al. 2010. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer, 116 (4), 791–798.
   PubMed Web of Science ®Google Scholar
• Anderson, R.A., et al. 2006. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Human Reproduction (Oxford, England), 21 (10), 2583–2592.
   PubMed Web of Science ®Google Scholar
• Berliere, M., et al. 2008. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer, 8, 56.
   PubMed Web of Science ®Google Scholar
• Bines, J., Oleske, D.M. and Cobleigh, M.A., 1996. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology : official Journal of the American Society of Clinical Oncology, 14 (5), 1718–1729.
   PubMed Web of Science ®Google Scholar
• Chipuk, J.E., et al. 2010. The BCL-2 family reunion. Molecular Cell, 37 (3), 299–310.
   PubMed Web of Science ®Google Scholar
• Davis, A.L., Klitus, M. and Mintzer, D.M., 2005. Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes. Clinical Breast Cancer, 6 (5), 421–424.
   PubMedGoogle Scholar
• DeSantis, C.E., et al. 2019. Breast cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69 (6), 438–451.
   PubMed Web of Science ®Google Scholar
• Fornier, M.N., et al. 2005. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer, 104 (8), 1575–1579.
   PubMed Web of Science ®Google Scholar
• Gadducci, A., Cosio, S. and Genazzani, A.R., 2007. Ovarian function and childbearing issues in breast cancer survivors. Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology, 23 (11), 625–631.
   PubMed Web of Science ®Google Scholar
• Ghoncheh, M., Pournamdar, Z. and Salehiniya, H., 2016. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pacific Journal of Cancer Prevention : APJCP, 17 (S3), 43–46.
   PubMedGoogle Scholar
• Gligorov, J. and Lotz, J.P., 2004. Preclinical pharmacology of the taxanes: implications of the differences. The Oncologist, 9 (S2), 3–8.
   PubMedGoogle Scholar
• Gücer, F., et al. 2001. Effect of paclitaxel on primordial follicular reserve in mice. Fertility and Sterility, 76 (3), 628–629.
   PubMed Web of Science ®Google Scholar
• Hortu, I., et al. 2020. Protective effect of oxytocin on a methotrexate-induced ovarian toxicity model. Archives of Gynecology and Obstetrics, 301 (5), 1317–1324.
   PubMed Web of Science ®Google Scholar
• Han, H.S., et al. 2009. Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. Breast Cancer Research and Treatment, 115 (2), 335–342.
   PubMed Web of Science ®Google Scholar
• Janssen, K., et al. 2007. Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood, 110 (10), 3662–3672.
   PubMed Web of Science ®Google Scholar
• Kai, S., et al. 1994. Reproductive and developmental toxicity studies of paclitaxel. (I)–Intravenous administration to rats prior to and in the early stages of pregnancy. The Journal of Toxicological Sciences, 19 (SupplementI), 57–67.
   PubMedGoogle Scholar
• Koyama, H., et al. 1977. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer, 39 (4), 1403–1409.
   PubMed Web of Science ®Google Scholar
• Kutuk, O. and Letai, A., 2010. Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells. Cell Death and Differentiation, 17 (10), 1624–1635.
   PubMed Web of Science ®Google Scholar
• Li, R., et al. 2005. Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell Death and Differentiation, 12 (3), 292–303.
   PubMed Web of Science ®Google Scholar
• Lopes, F., et al. 2014. Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles. Molecular Human Reproduction, 20 (10), 948–959.
   PubMed Web of Science ®Google Scholar
• Martin, M., Breast Cancer International Research Group 001 Investigators., et al. 2005. Adjuvant docetaxel for node-positive breast cancer. The New England Journal of Medicine, 352 (22), 2302–2313.
   PubMed Web of Science ®Google Scholar
• McGee, E.A. and Hsueh, A.J.W., 2000. Initial and cyclic recruitment of ovarian follicles. Endocrine Reviews, 21 (2), 200–214.
   PubMed Web of Science ®Google Scholar
• Meirow, D., et al. 2007. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Human Reproduction (Oxford, England), 22 (6), 1626–1633.
   PubMed Web of Science ®Google Scholar
• Minisini, A.M., et al. 2009. Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era. Anti-Cancer Drugs, 20 (6), 503–507.
   PubMed Web of Science ®Google Scholar
• Morgan, S., et al. 2013. Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin. PLOS One, 8 (7), e70117.
   PubMed Web of Science ®Google Scholar
• Nicosia, S.V., Matus-Ridley, M. and Meadows, A.T., 1985. Gonadal effects of cancer therapy in girls. Cancer, 55 (10), 2364–2372.
   PubMed Web of Science ®Google Scholar
• Pérez-Fidalgo, J.A., et al. 2010. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Research and Treatment, 120 (1), 245–251.
   PubMed Web of Science ®Google Scholar
• Reh, A., Oktem, O. and Oktay, K., 2008. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertility and Sterility, 90 (5), 1635–1639.
   PubMed Web of Science ®Google Scholar
• Reichman, B.S. and Green, K.B., 1994. Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects. Journal of National Cancer Institute Monographs, 16, 125–129.
   Google Scholar
• Rojas, K. and Stuckey, A., 2016. Breast cancer epidemiology and risk factors. Clinical Obstetrics and Gynecology, 59 (4), 651–672.
   PubMed Web of Science ®Google Scholar
• Roness, H., et al. 2013. Ovarian follicle burnout: a universal phenomenon? Cell Cycle (Georgetown, Tex.), 12 (20), 3245–3246.
   PubMed Web of Science ®Google Scholar
• Sunters, A., et al. 2003. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. The Journal of Biological Chemistry, 278 (50), 49795–49805.
   PubMed Web of Science ®Google Scholar
• Tan, T.T., et al. 2005. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell, 7 (3), 227–238.
   PubMed Web of Science ®Google Scholar
• Tarumi, W., et al. 2009. Ovarian toxicity of paclitaxel and effect on fertility in the rat. The Journal of Obstetrics and Gynaecology Research, 35 (3), 414–420.
   PubMed Web of Science ®Google Scholar
• Tham, Y.L., et al. 2007. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. American Journal of Clinical Oncology, 30 (2), 126–132.
   PubMed Web of Science ®Google Scholar
• Thomson, T.C., Fitzpatrick, K.E. and Johnson, J., 2010. Intrinsic and extrinsic mechanisms of oocyte loss. Molecular Human Reproduction, 16 (12), 916–927.
   PubMed Web of Science ®Google Scholar
• Youle, R.J. and Strasser, A., 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nature Reviews. Molecular Cell Biology, 9 (1), 47–59.
   PubMed Web of Science ®Google Scholar
• Yucebilgin, M.S., et al. 2004. Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 44 (1), 6–9.
   PubMed Web of Science ®Google Scholar
• Zhou, W.B., et al. 2010. Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and Navelbine in younger breast cancer patients. BMC Cancer, 10, 281.
   PubMed Web of Science ®Google Scholar